Platelets and their microparticles as key players in pathophysiological responses

D Varon, E Shai - Journal of Thrombosis and Haemostasis, 2015 - Wiley Online Library
Platelets are known to play a central role in primary hemostasis as well as in the
pathophysiology of thrombotic disorders. However, in addition to hemostasis, platelets are …

Origin and production of inflammatory perivascular macrophages in pulmonary hypertension

J Florentin, P Dutta - Cytokine, 2017 - Elsevier
Myeloid cells, including monocytes and macrophages participate in steady state immune
homeostasis and help mount the adaptive immune response during infection. The function …

The role of macrophages in pulmonary hypertension: Pathogenesis and targeting

S Chen, D Yan, A Qiu - International Immunopharmacology, 2020 - Elsevier
Pulmonary hypertension (PH) is a pathophysiological disorder that can complicate most
cardiovascular and respiratory diseases and may involve multiple clinical conditions, but its …

Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: A preliminary study

P Jurasz, D Ng, JT Granton, DW Courtman… - Thrombosis research, 2010 - Elsevier
INTRODUCTION: Idiopathic pulmonary arterial hypertension (IPAH) is characterized by
pulmonary arteriolar narrowing and degeneration associated with in situ thrombosis. We …

Novel targets of drug treatment for pulmonary hypertension

J Hu, Q Xu, C McTiernan, YC Lai… - American Journal of …, 2015 - Springer
Biomedical advances over the last decade have identified the central role of proliferative
pulmonary arterial smooth muscle cells (PASMCs) in the development of pulmonary …

[HTML][HTML] Coagulation profiles of pulmonary arterial hypertension patients, assessed by non-conventional hemostatic tests and markers of platelet activation and …

E Vrigkou, AE Tsantes, P Kopterides, SE Orfanos… - Diagnostics, 2020 - mdpi.com
Many pathophysiologic processes of pulmonary arterial hypertension (PAH), namely, excess
vasoconstriction, vascular remodeling and in situ thrombosis, involve the coagulation …

[HTML][HTML] Platelets are at the nexus of vascular diseases

H Lebas, K Yahiaoui, R Martos… - Frontiers in cardiovascular …, 2019 - frontiersin.org
Platelets are important actors of cardiovascular diseases (CVD). Current antiplatelet drugs
that inhibit platelet aggregation have been shown to be effective in CVD treatment. However …

[PDF][PDF] Microparticles: a component of various diseases

M Budaj, Z Poljak, I Ďuriš, M Kaško, R Imrich… - Pol. Arch. Med …, 2012 - researchgate.net
Microparticles (MPs) are phenotypically and functionally heterogeneous population of
microvesicles. Although MP formation represents a physiological phenomenon. A multitude …

Emerging therapies and future directions in pulmonary arterial hypertension

V Gurtu, ED Michelakis - Canadian Journal of Cardiology, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is a complex obliterative vascular disease. It remains
deadly despite an explosion of basic research over the past 20 years that identified myriads …

Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine

T Burnouf, HA Goubran, ML Chou, D Devos… - Blood reviews, 2014 - Elsevier
There is increasing research on and clinical interest in the physiological role played by
platelet microparticles (PMPs). PMPs are 0.1–1-μm fragments shed from plasma …